{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:03:29Z","timestamp":1773770609247,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jiac.2026.102934","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:56:50Z","timestamp":1771433810000},"page":"102934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe polyneuropathy in HIV-negative human herpesvirus 8\u2013associated multicentric Castleman disease successfully treated with rituximab and liposomal doxorubicin"],"prefix":"10.1016","volume":"32","author":[{"given":"Saki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harutaka","family":"Katano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Samori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuto","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-5961","authenticated-orcid":false,"given":"Akihiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-2422","authenticated-orcid":false,"given":"Satoshi","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiac.2026.102934_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease","volume":"7","author":"Carbone","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"16","key":"10.1016\/j.jiac.2026.102934_bib2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jiac.2026.102934_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<159::AID-JMV12>3.0.CO;2-A","article-title":"Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan","volume":"57","author":"Fujii","year":"1999","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.jiac.2026.102934_bib4","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1128\/JVI.73.10.8268-8278.1999","article-title":"Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6","volume":"73","author":"Wan","year":"1999","journal-title":"J Virol"},{"issue":"25","key":"10.1016\/j.jiac.2026.102934_bib5","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood.2019004602","article-title":"Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"135","author":"Ramaswami","year":"2020","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jiac.2026.102934_bib6","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","article-title":"Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB trial","volume":"25","author":"G\u00e9rard","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jiac.2026.102934_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/0003-4819-147-12-200712180-00003","article-title":"Brief communication: Rituximab in HIV-associated multicentric Castleman disease","volume":"147","author":"Bower","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jiac.2026.102934_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CCO.0b013e328355e0f3","article-title":"Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"24","author":"Uldrick","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.jiac.2026.102934_bib9","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2023-181542","article-title":"KSHV\/HHV-8 associated multicentric castleman disease in 80 HIV negative patients","volume":"142","author":"Stemmler","year":"2023","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jiac.2026.102934_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14186563","article-title":"Castleman disease and kaposi sarcoma: a review of the literature and a case series","volume":"14","author":"Denaro","year":"2025","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jiac.2026.102934_bib11","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/bloodadvances.2020004058","article-title":"Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases","volume":"5","author":"Ramaswami","year":"2021","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.jiac.2026.102934_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ajh.26240","article-title":"POEMS syndrome: 2021 update on diagnosis, risk-stratification, and management","volume":"96","author":"Dispenzieri","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jiac.2026.102934_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri","year":"2007","journal-title":"Blood Rev"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:54:02Z","timestamp":1773759242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1341321X26000322"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102934","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe polyneuropathy in HIV-negative human herpesvirus 8\u2013associated multicentric Castleman disease successfully treated with rituximab and liposomal doxorubicin","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102934"}}